Applied DNA Sciences Rebrands to BNB Plus Corp.

Tip Ranks
2025.11.17 21:56
portai
I'm PortAI, I can summarize articles.

Applied DNA Sciences has rebranded to BNB Plus Corp., effective November 13, 2025, with a new focus on BNB-based digital asset treasury strategies. The ticker has changed to BNBX, and Josh Kruger is appointed as Chairman of the Board. Despite strategic moves, the company faces financial challenges, with Spark's AI Analyst rating BNBX as Neutral due to declining revenues and poor technical indicators.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

The latest announcement is out from Applied DNA Sciences ( (BNBX) ).

On November 13, 2025, Applied DNA Sciences officially changed its name to BNB Plus Corp., aligning with its new focus on a BNB-based digital asset treasury strategy. The rebranding, which includes a ticker change to BNBX, reflects the company’s commitment to leveraging Binance-native tools for yield generation and capital efficiency. Additionally, Josh Kruger was appointed as Chairman of the Board, signaling a strengthened leadership in decentralized finance (DeFi). This move is expected to enhance the company’s market positioning and unlock new shareholder value as it expands its BNB holdings.

Spark’s Take on BNBX Stock

According to Spark, TipRanks’ AI Analyst, BNBX is a Neutral.

Applied DNA Sciences faces substantial financial and operational challenges, as indicated by declining revenues and net losses. Despite some positive strategic moves, such as focusing on LineaRx, the stock suffers from poor technical indicators and valuation metrics. The company’s ongoing financial struggles and the uncertainties highlighted in the earnings call contribute to a low overall stock score.

To see Spark’s full report on BNBX stock, click here.

More about Applied DNA Sciences

BNB Plus Corp., formerly known as Applied DNA Sciences, operates in the blockchain and digital asset industry. The company focuses on delivering yield-optimized, BNB-based digital asset treasury strategies leveraging the Binance ecosystem. It also continues to commercialize proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.

Average Trading Volume: 1,334,812

Technical Sentiment Signal: Strong Sell

Current Market Cap: $12.41M

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer